Ding‐Ding Guo
Impact in
- Hematology top 2%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Antibiotic Resistance in Bacteria 3
-
- Vibrio bacteria research studies 3
- Co-authors
- Chong‐Su Cho (4 shared papers)James N. George (1 shared paper)Ji-shan Quan (2 shared papers)Michael D. Tarantino (1 shared paper)Louis M. Aledort (1 shared paper)Terry Gernsheimer (1 shared paper)Janet Lee Nichol (1 shared paper)Myung‐Haing Cho (2 shared papers)
- Journals
- Biomaterials (2 papers)Phytomedicine (1 paper)Frontiers in Earth Science (1 paper)Journal of Asian Natural Products Research (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Ding‐Ding Guo
20 papers receiving 1.1k citations
Ding‐Ding Guo's Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 740
- Genetics 131
- Molecular Medicine 61
- Pathology and Forensic Medicine 165
- Pharmaceutical Science 52
Countries citing papers authored by Ding‐Ding Guo
This map shows the geographic impact of Ding‐Ding Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding‐Ding Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding‐Ding Guo more than expected).
Fields of papers citing papers by Ding‐Ding Guo
This network shows the impact of papers produced by Ding‐Ding Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding‐Ding Guo. The network helps show where Ding‐Ding Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding‐Ding Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial Hit paper breakdown → | 2008 | 716 |
| 2 | 2010 | 86 | |
| 3 | 2009 | 63 | |
| 4 | 2020 | 51 | |
| 5 | 2011 | 45 | |
| 6 | 2008 | 41 | |
| 7 | 2014 | 26 | |
| 8 | 2014 | 25 | |
| 9 | 2019 | 21 | |
| 10 | 2021 | 17 | |
| 11 | 2011 | 15 | |
| 12 | 2014 | 12 | |
| 13 | 2020 | 9 | |
| 14 | 2016 | 9 | |
| 15 | 2023 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2021 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 2 | |
| 20 | [Study on the content of imperatorin and HPLC fingerprint of Baizhi collected from different areas]. | 2010 | 2 |
About Ding‐Ding Guo
Ding‐Ding Guo is a scholar working on Molecular Medicine, Endocrinology, Hematology, Ocean Engineering and Safety, Risk, Reliability and Quality, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (4 papers), Bacterial Genetics and Biotechnology (3 papers), Antibiotic Resistance in Bacteria (3 papers), Platelet Disorders and Treatments (3 papers), Vibrio bacteria research studies (3 papers), Coal Properties and Utilization (3 papers), Rock Mechanics and Modeling (2 papers) and Geoscience and Mining Technology (2 papers). The work is most often cited by research in Hematology (740 citations), Genetics (131 citations), Molecular Medicine (61 citations), Pathology and Forensic Medicine (165 citations) and Pharmaceutical Science (52 citations). Ding‐Ding Guo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Chong‐Su Cho, James N. George, Ji-shan Quan, Michael D. Tarantino, Louis M. Aledort, Terry Gernsheimer, Janet Lee Nichol, Myung‐Haing Cho, Yun‐Jaie Choi and Yong‐Xing He. Their work appears in journals such as Biomaterials, Phytomedicine, Frontiers in Earth Science, Journal of Asian Natural Products Research and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.